Menu

Blog

Archive for the ‘biotech/medical’ category: Page 1241

Nov 6, 2021

The world’s first hydrogen cargo bike is the future of transportation as it runs without batteries!

Posted by in categories: biotech/medical, transportation

The LAVO bike from StudioMOM is the world’s first hydrogen bike, requiring no heavy batteries, particulates, or CO2 emissions for operation.

Nowadays, it seems bikes are the preferred mode of transportation in crowded cities. Traffic is no joke and public transportation has seen some major changes since the onset of the COVID-19 pandemic, so people are hitting the streets with shiny electric and portable bicycles. While bikes are generally more environmentally friendly than cars and trucks, they come with their own list of setbacks. Becoming the world’s first hydrogen bike, the LAVO bike from StudioMOM is a small solution to a big problem.

Nov 6, 2021

Artificial intelligence is getting better at writing, and universities should worry about plagiarism

Posted by in categories: biotech/medical, climatology, robotics/AI, surveillance

The dramatic rise of online learning during the COVID-19 pandemic has spotlit concerns about the role of technology in exam surveillance — and also in student cheating.

Some universities have reported more cheating during the pandemic, and such concerns are unfolding in a climate where technologies that allow for the automation of writing continue to improve.

Over the past two years, the ability of artificial intelligence to generate writing has leapt forward significantly, particularly with the development of what’s known as the language generator GPT-3. With this, companies such as Google, Microsoft, and NVIDIA can now produce “human-like” text.

Nov 6, 2021

Gwen Darien — EVP, Patient Advocacy and Engagement, National Patient Advocate Foundation

Posted by in categories: biotech/medical, finance, health, policy

EVP, patient advocacy & engagement, national patient advocate foundation.


Gwen Darien is Executive Vice President for Patient Advocacy and Engagement, at the National Patient Advocate Foundation (https://www.npaf.org/), an organization with a mission of bringing patient voices to health system delivery reform, developing and driving initiatives promoting equitable access to affordable quality health care, and prioritizing the patient voice in health system delivery reform to achieve person-centered care. She is also Executive Vice President at their sister organization, Patient Advocate Foundation (https://www.patientadvocate.org/), a national non-profit organization which provides case management services and financial aid to Americans with chronic, life threatening and debilitating illnesses.

Continue reading “Gwen Darien — EVP, Patient Advocacy and Engagement, National Patient Advocate Foundation” »

Nov 6, 2021

Europe is once again “at the epicentre” of the #Covid19 pandemic, the WHO has warned, as cases soar across the continent

Posted by in category: biotech/medical

It came as Germany recorded more than 37,000 daily Covid cases on Friday, a record high for the second day running. Austria’s daily new coronavirus infections surged towards a record set a year ago, making a lockdown for the unvaccinated ever more likely. The most dramatic rises in fatalities have been in the past week in Russia, where more than 8,100 deaths were recorded, and Ukraine, with 3,800 deaths. Both countries have very low rates of vaccination and Ukraine announced a record 28,000 new cases in the past 24 hours. (5 Nov 2021)

Nov 6, 2021

Google-Parent Alphabet Has Set Up a New Lab That Will Use A.I. to Try to Discover New Drugs

Posted by in categories: biotech/medical, robotics/AI

Alphabet has launched a new drug discovery company called Isomorphic Labs that will be led by DeepMind CEO Demis Hassabis.

Nov 5, 2021

Can Artificial Intelligence Save America From The Global Supply Chain Disaster?

Posted by in categories: biotech/medical, food, robotics/AI

The issue facing the world today is not simply “THE supply chain,” the issue is that nearly every single link in the supply chain is compromised. Human talent is less available and manufacturers fear this will become a permanent reality, even after the pandemic. Extreme weather events occur every month and the ongoing pandemic is also causing shortages of direct and indirect materials. In turn, shipping costs have risen sharply. The status of sheet metal, computer chips and all food ingredients are up in the air. Constraints on the supply of raw materials, including those needed for semiconductors, PPE and various plastics, have led to factory shutdowns. A chronic lack of truck drivers has every neighborhood filled empty store shelves staring back at its citizens. And, to no surprise, Inflation was just reported at 5.4%, which is a 13 year high.

Now consider that only 4% of supply chain leaders believe their operations are future ready. We are at the precipice of either complete disaster, or a brave new world.

Nov 5, 2021

New way to infiltrate hard-to-treat cancers

Posted by in category: biotech/medical

Scientists have found a way to deactivate DDR1, a molecule that forms a barrier ‘like barbed wire’ in tumours. By removing this barrier, anti-tumour immune cells could target aggressive forms of breast cancer.

Nov 5, 2021

Scientists Discover a Novel Therapeutic Target To Treat Fatty Liver Disease

Posted by in category: biotech/medical

About 80 million Americans have fatty liver disease unrelated to alcohol abuse. Nonalcoholic fatty liver disease is associated with obesity and diabetes, and can lead to more severe liver damage such as nonalcoholic steatohepatitis (NASH), cirrhosis and liver cancer. Cardiovascular disease, colorectal cancer and breast cancer actually are the major causes of death in patients with fatty liver disease.

Several drugs in advanced stages of development have failed because of the complexity of the disease, low efficacy, or the toxicity of drugs. Although several clinical trials were conducted in past decades, currently there is no FDA-approved pharmaceutical therapy for NASH.

To understand the complexity of the progression of fatty liver disease, a team of USC.

Nov 5, 2021

Plans Of A Technocratic Elite: ‘The Great Reset’ Is Not A Conspiracy Theory

Posted by in categories: 3D printing, biotech/medical, genetics, information science, internet, nanotechnology, quantum physics, Ray Kurzweil, robotics/AI, singularity, transhumanism

According to Klaus Schwab, the founder and executive chair of the World Economic Forum (WEF), the 4-IR follows the first, second, and third Industrial Revolutions—the mechanical, electrical, and digital, respectively. The 4-IR builds on the digital revolution, but Schwab sees the 4-IR as an exponential takeoff and convergence of existing and emerging fields, including Big Data; artificial intelligence; machine learning; quantum computing; and genetics, nanotechnology, and robotics. The consequence is the merging of the physical, digital, and biological worlds. The blurring of these categories ultimately challenges the very ontologies by which we understand ourselves and the world, including “what it means to be human.”

The specific applications that make up the 4-R are too numerous and sundry to treat in full, but they include a ubiquitous internet, the internet of things, the internet of bodies, autonomous vehicles, smart cities, 3D printing, nanotechnology, biotechnology, materials science, energy storage, and more.

While Schwab and the WEF promote a particular vision for the 4-IR, the developments he announces are not his brainchildren, and there is nothing original about his formulations. Transhumanists and Singularitarians (or prophets of the technological singularity), such as Ray Kurzweil and many others, forecasted these and more revolutionary developments,. long before Schwab heralded them. The significance of Schwab and the WEF’s take on the new technological revolution is the attempt to harness it to a particular end, presumably “a fairer, greener future.”

Nov 5, 2021

Physicists Discover How DNA Molecules Self-Assemble: Laws of Nature Harnessed To Create “Smart Materials”

Posted by in categories: biotech/medical, genetics

A team of physicists has discovered how DNA

DNA, or deoxyribonucleic acid, is a molecule composed of two long strands of nucleotides that coil around each other to form a double helix. It is the hereditary material in humans and almost all other organisms that carries genetic instructions for development, functioning, growth, and reproduction. Nearly every cell in a person’s body has the same DNA. Most DNA is located in the cell nucleus (where it is called nuclear DNA), but a small amount of DNA can also be found in the mitochondria (where it is called mitochondrial DNA or mtDNA).